Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest reportAt approximately 10.30 today (10 June 2016), there was a small emission of a non-radioactive substance at Urenco Stable Isotopes on the Almelo site in the Netherlands. The substance, germanium fluoride is a corrosive substance that reacts with condensation in the air to form hydrogen fluoride. Five firemen were found to have inhaled the substance and were taken to hospital. Two Urenco employees were also taken to hospital but were released shortly afterwards.
The installation was immediately put into safe mode and the incident was reported to the authorities. A full investigation will be carried out in due course.
We have teamed up with the Dutch university Tu Delft to develop new generations of nuclear scientists.
Read more Urenco partners with leading nuclear university to invest in talentWe have teamed up with the Dutch university Tu Delft to develop new generations of nuclear scientists.
Read more Urenco partners with leading nuclear university to invest in talentGetting closer to achieving our near-term emissions target by 2030
Read more Urenco’s Netherlands site is to be powered with low-carbon electricity from a nuclear power stationGetting closer to achieving our near-term emissions target by 2030
Read more Urenco’s Netherlands site is to be powered with low-carbon electricity from a nuclear power stationAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries